メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
富山大学 ホーム
日本語
English
ホーム
プロファイル
研究部門
プロジェクト
研究成果
データセット
受賞
活動
コース
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
朴木 博幸
助教, 博士（医学） 富山大学 2007年3月
内科学（第一）講座
h-index
454
被引用数
11
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2006
2024
年別の研究成果
概要
フィンガープリント
ネットワーク
プロジェクト
(2)
研究成果
(11)
類似のプロファイル
(6)
フィンガープリント
Hiroyuki Honokiが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Keyphrases
C-Fos
80%
Osteoclastogenesis
79%
NFATc1
77%
Tumor Necrosis Factor-α
60%
Peroxisome Proliferator-activated Receptor
51%
Rheumatoid Arthritis
45%
Rituximab
38%
Systemic Lupus Erythematosus
38%
Older Men
33%
RAW264.7 Cells
33%
Induced Expression
31%
Receptor Activator of nuclear factor-B Ligand
30%
Rituximab Therapy
30%
C-Jun
29%
Osteoclast Differentiation
28%
Autoimmune Hemolytic Anemia
28%
Osteoclast
27%
Cytophagic Histiocytic Panniculitis
25%
Behet's Disease
25%
Tuberculosis
25%
Disease-associated
25%
Incidental Detection
25%
Methotrexate Treatment
25%
Pranlukast
25%
Regulated on Activation
25%
Presenting Manifestation
25%
Inhaled Corticosteroids
25%
Warm Autoantibody
25%
Infliximab
25%
Inositol 1,4,5-trisphosphate Receptor (IP3R)
25%
Disease Activity
25%
Alanine Aminotransferase
25%
Ascending Lumbar Vein
25%
Isoproterenol
25%
Pleiotropic Effects
25%
Mouse Kidney
25%
Lactate Dehydrogenase
25%
Bone Scintigraphy
25%
Aminotransferase
25%
Tumor Progression Locus 2
25%
Hydrolases
25%
Primary Sjgren's Syndrome
25%
Infliximab Therapy
25%
Male Patients
25%
Receptor-interacting Protein Kinase 1 (RIPK1)
25%
Protein Kinase
25%
Polymyositis
25%
Central Venous Catheter
25%
Cannulation
25%
Creatine Kinase
25%
Medicine and Dentistry
Osteoclastogenesis
58%
Tumor Necrosis Factor
51%
Disease
47%
Rheumatoid Arthritis
40%
Inflammatory Arthritis
40%
Lupus Erythematosus Panniculitis
38%
Systemic Lupus Erythematosus
38%
Rituximab
38%
Receptor
32%
Transcription Factor NFAT
29%
Oncogene C Fos
29%
Osteoclast Differentiation Factor
28%
Peroxisome Proliferator Activated Receptor Gamma Agonist
25%
Recurrent Disease
25%
Methotrexate
25%
Hemophagocytic Syndrome
25%
Infliximab
25%
Idiopathic Interstitial Pneumonia
25%
IgG4-Related Disease
25%
Downregulation
25%
Tumor Progression
25%
Weight Bearing
25%
Bone Scintigraphy
25%
Central Venous Catheter
25%
Cannulation
25%
Protein Kinases
25%
Osteoplasty
25%
Nuclear Factor
25%
Alternative Complement Pathway C3 C5 Convertase
25%
Pleiotropy
25%
Peroxisome Proliferator Activated Receptor
25%
Monocyte Chemotactic Protein 1
25%
Bone Remodeling
25%
Osteoclast
17%
Ciglitazone
16%
Prostaglandin J2
16%
Osteolysis
16%
Interstitial Lung Disease
15%
Ulcer
15%
Acid Phosphatase Tartrate Resistant Isoenzyme
14%
Prednisolone
13%
Peroxisome Proliferator Activated Receptor Gamma
12%
Amino Acid Transfer RNA Ligase
12%
Thrombotic Thrombocytopenic Purpura
12%
Mitogen-Activated Protein Kinase
12%
Arm
12%
Ossification
12%
Immunoprecipitation
12%
Dermatomyositis
12%
Pancytopenia
11%
Immunology and Microbiology
Osteoclastogenesis
100%
RANKL
82%
Oncogene C Fos
80%
Downregulation
51%
Peroxisome
51%
Agonist
47%
Bone Marrow Cell
34%
Complement Factor B
31%
Amino Terminal Sequence
31%
Tumor Necrosis Factor
30%
Osteoclast
29%
Cytokine
29%
Transcription Factor NFAT
29%
Pleiotropy
25%
Interleukin 10
25%
Monocyte Chemotactic Protein 1
25%
Interleukin 4
25%
Polymyositis
25%
Systemic Lupus Erythematosus
25%
Secretion (Process)
25%
Bone Remodeling
25%
Autoimmune Hemolytic Anemia
25%
T Cell
25%
Autoimmune Hepatitis
25%
Hemophagocytic Lymphohistiocytosis
25%
Autoantibodies
25%
Immunoglobulin M
25%
Isoprenaline
25%
Dermatomyositis
17%
Prostaglandin J2
16%
Transcription Factors
15%
Inflammatory Arthritis
14%
Osteolysis
13%
Prednisolone
13%
Immunoprecipitation
12%
Immunology
12%
Macrophage Colony-Stimulating Factor
11%
Macrophage
10%
Immunoglobulin M Antibody
10%
Gene Expression
9%
Protein Expression
9%
Asthma
8%
Ossification
8%
Dentin Slice
8%
Antisynthetase Syndrome
7%
Interleukin-4 Receptor
6%
Dentin
6%
Macrophage Cell Line
5%
Inflammatory Cytokine
5%
Precursor
5%
